Abstract: FR-PO818
Goal Attainment Scale as an Outcome Measure in a Randomized Controlled Trial of Lifestyle Interventions
Session Information
- Health Maintenance, Nutrition, Metabolism - II
November 03, 2023 | Location: Exhibit Hall, Pennsylvania Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Health Maintenance, Nutrition, and Metabolism
- 1500 Health Maintenance, Nutrition, and Metabolism
Authors
- Jegatheesan, Dev Krish, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
- Pinzon Perez, William F., Queensland Cyber Infrastructure Foundation, Saint Lucia, Queensland, Australia
- Brown, Riley, The University of Queensland, Saint Lucia, Queensland, Australia
- Burton, Nicola W., Griffith University, Nathan, Queensland, Australia
- Webb, Lindsey, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
- Barnett, Amandine, The University of Queensland, Saint Lucia, Queensland, Australia
- Conley, Marguerite M., Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
- Mayr, Hannah L., The University of Queensland, Saint Lucia, Queensland, Australia
- Keating, Shelley, The University of Queensland, Saint Lucia, Queensland, Australia
- Kelly, Jaimon T., The University of Queensland, Saint Lucia, Queensland, Australia
- Macdonald, Graeme A., The University of Queensland, Saint Lucia, Queensland, Australia
- Coombes, Jeff S., The University of Queensland, Saint Lucia, Queensland, Australia
- Hickman, Ingrid J., The University of Queensland, Saint Lucia, Queensland, Australia
- Isbel, Nicole, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
Background
Goal attainment scale (GAS) is a validated patient-reported outcome measure (PROM) that can be used to quantitate achievement of individualised patient goals. GAS has not been assessed as a PROM in lifestyle intervention trials. We report the GAS findings of a predefined sub-analysis of the U-DECIDE study, which assessed the feasibility of digital health-assisted lifestyle interventions (DHALI) in people with kidney and liver disease.
Methods
Adults with kidney or liver disease and metabolic syndrome were randomized to either usual care (UC) or DHALI+UC. All participants received goal setting support, a wearable activity monitor, and individualized dietitian counselling. The DHALI+UC group could opt-in to receive exercise and/or dietetic video consultations; had access to nutrition and exercise applications; and text-message education. Pre-randomization, participants were assisted by a clinician to generate up to 2 SMART (specific, measurable, attainable, realistic and timely) lifestyle goals. Possible outcomes (‘much better than expected’, ‘better than expected’, ‘as expected’, ‘worse than expected’, ‘much worse than expected’) for each goal were predetermined and quantified by the participants. The ΔGAS score was calculated for each participant at the end of the trial by using a validated formula which incorporated the importance, difficulty and outcome scores of each goal.
Results
67 participants were randomized, 46 (70%) with kidney disease. Mean age was 51 ± 13 years, 56% were men. Participants set weight loss (46%), followed by fitness (29%), dietary (15%) and body composition (5%) goals. 66 (99%) participants completed both goal setting (at baseline) and outcome review (at 26 weeks) sessions, each taking <10 minutes per patient. Though underpowered for this outcome, there was no significant difference in ΔGAS between UC and DHALI+UC groups (7 vs 6, p = 0.578) over time.
Conclusion
Participants commonly selected weight loss and fitness goals. GAS is a feasible, convenient and inexpensive PROM that can be used to quantitate change in patient determined lifestyle goals.